New Jersey Launches Investigation of Amgen’s Enbrel Marketing Practices
This article was originally published in The Pink Sheet Daily
State attorney general subpoenas Amgen in the wake of lawsuits filed by former sales reps that allege off-label marketing.
You may also be interested in...
Purdue pleads guilty to illegally promoting and selling the painkiller, ending an investigation by the U.S. Attorney’s Office in Virginia.
FDA guidances have provided ‘major step forward’ for use of social media data, Roche researcher notes. Agency staffer offers checklist for collecting patient experience data in this realm.
Agency staff note hurdles in obtaining evidence outlined in FDA’s patient-focused drug development guidance to support regulatory decision-making.